Customer Service:
Mon - Fri: 8:30 am - 6 pm EST

 Historical

ISO 22442-1:2007

Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management

ISO 22442-1:2007 applies to medical devices other than in vitro diagnostic medical devices manufactured utilizing materials of animal origin, which are non-viable or have been rendered non-viable. It specifies, in conjunction with ISO 14971, a procedure to identify the hazards and hazardous situations associated with such devices, to estimate and evaluate the resulting risks, to control these risks, and to monitor the effectiveness of that control. Furthermore, it outlines the decision process for the residual risk acceptability, taking into account the balance of residual risk, as defined in ISO 14971, and expected medical benefit as compared to available alternatives. ISO 22442-1:2007 is intended to provide requirements and guidance on risk management related to the hazards typical of medical devices manufactured utilizing animal tissues or derivatives such as:

  • contamination by bacteria, moulds or yeasts;
  • contamination by viruses;
  • contamination by agents causing Transmissible Spongiform Encephalopathies (TSE);
  • material responsible for undesired pyrogenic, immunological or toxicological reactions.


Content Provider
International Organization for Standardization [iso]


Others Also Bought

Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and ...
Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or ...
Information supplied by the manufacturer of medical devices (British Standard)
Document History
Revised By:
Included in Packages
This standard is not included in any packages.
Amendments & Corrections
We have no amendments or corrections for this standard.
ANSI Logo

As the voice of the U.S. standards and conformity assessment system, the American National Standards Institute (ANSI) empowers its members and constituents to strengthen the U.S. marketplace position in the global economy while helping to assure the safety and health of consumers and the protection of the environment.

CUSTOMER SERVICE
NEW YORK OFFICE
ANSI HEADQUARTERS